SmileDirectClub vs. Dentsply Sirona: Which Dental Stock Is a Better Investment?

: SDC | SmileDirectClub Inc. News, Ratings, and Charts

SDC – The global dental market is forecast to see significant growth in the coming years. So today, I’ll analyze SmileDirectClub (SDC) and Dentsply Sirona (XRAY), to determine which dental stock is a better buy.

The global middle-class is getting larger every year.  It’s forecast that the global middle-class will reach 5.3 billion people by 2030, up from an estimated 2 billion in 2020.

With this growth, the global dental market will benefit. This market is expected to reach $37.16 billion by 2025, from $30.05 billion in 2019.

With this in mind, today I’ll take a look at two dental stocks, SmileDirectClub (SDC) and Dentsply Sirona (XRAY), to see which is currently the better investment. 

SmileDirectClub is popular on Reddit

SmileDirectClub is an oral-care company that offers clear aligner therapy treatments. Valued at a market cap of $2.23 billion, SDC manages the entire process from aligner manufacturing to marketing, treatment, and monitoring. It has a network of 250 state-licensed general dentists and licensed orthodontists.

SDC stock is trending on social media platform Reddit but it is down 14.8% in the last month and declined by 71% from record highs. SmileDirectClub sales rose by 63% year over year in Q2 to $174 million but were still 24% lower compared to sales in the same period in 2019.

Analysts tracking the stock forecast sales to rise by 15.6% in 2021 to $759.25 million and by 20.4% to $914 million next year. But it also estimates to report a net loss per share of $0.68 in 2021 and $0.3 in 2022.

SmileDirectClub’s forward price to sales multiple of less than 3x is quite reasonable given the growth forecasts. Wall Street expects SDC stock to touch $6.95 in the next 12-months which is 22% above the current trading price.

Dentsply Sirona has a market cap of over $13 billion

Dentsply Sirona is much larger compared to SDC and is valued at a market cap of $13 billion. It designs, develops, manufactures, and sells multiple dental products and technologies for the professional dental market worldwide. It has two primary business segments that include Technologies & Equipment and Consumables.

The company’s sales fell from $4 billion in 2019 to $3.3 billion in 2020. Its operating income also fell from $441.6 million to $222 million in this period. However, while COVID-19 impacted the financials of Dentsply last year, analysts expect sales to rise by 28.4% to $4.29 billion in 2021 and by 5.2% to $4.51 billion in 2022. This will enable Dentsply to increase its earnings at an annual rate of 26.35% in the next five years.

The stock is trading at a forward price to earnings multiple of 20.7x and a price to sales multiple of 3.1 which is similar to SDC. Wall Street also expects Dentsply stock to touch $72.73 in the next year, which is 23% higher than its current price.

The company’s consistent profits enabled the management team to increase quarterly dividends per share by 10% to $0.11 in May, indicating a yield of 0.74%.

The verdict

Earlier this year, Dentsply Sirona announced the acquisition of Propel Orthodontics for $113 million in cash. This purchase will help Dentsply to gain traction in the clear-aligner market which is forecast to grow to $8.7 billion by 2028, from just $2.4 billion in 2020.

Further, Dentsply’s expanding bottom-line and stable cash flows make it a better investment compared to SmileDirectClub, as the former is better equipped to handle macroeconomic shocks. 


SDC shares were trading at $5.68 per share on Friday afternoon, down $0.42 (-6.89%). Year-to-date, SDC has declined -52.43%, versus a 19.78% rise in the benchmark S&P 500 index during the same period.


About the Author: Aditya Raghunath


Aditya Raghunath is a financial journalist who writes about business, public equities, and personal finance. His work has been published on several digital platforms in the U.S. and Canada, including The Motley Fool, Finscreener, and Market Realist. More...


More Resources for the Stocks in this Article

TickerPOWR RatingIndustry RankRank in Industry
SDCGet RatingGet RatingGet Rating
XRAYGet RatingGet RatingGet Rating

Most Popular Stories on StockNews.com


:  |  News, Ratings, and Charts

How to Beat the Market the Rest of the Year?

The easy gains that came at the start of this new bull market are fading away fast. In fact the stock market (SPY) has become quite volatile with 2022 starting off with a nasty correction. Gladly there are easy solutions as will be shared in this commentary to get you on the right path to outperform the market the rest of the year. Read the rest below...

:  |  News, Ratings, and Charts

3 Stocks that Are Thriving in an Inflationary Environment

Inflation is one of the biggest threats facing the economy. One profitable strategy during this period of high inflation is to focus on stocks that have pricing power, as these companies’ margins will continue to expand. In contrast, stocks without pricing power are likely to underperform as margin compression erodes EPS. Therefore, investors should consider buying these 3 stocks that are thriving in this inflationary environment: Olin (OLN), Nucor (NUE), and Chemours (CC).

:  |  News, Ratings, and Charts

Stock Market “Nausea Index” Going Off

The stock market (SPY) has seen fresh lows this week scaring many investors into selling their positions. On the other hand, 40 year investment veteran shares a proprietary market indicator that points to a significant bounce coming soon. Is he right? You be the judge by reading below.

:  |  News, Ratings, and Charts

4 Best Value Stocks to Buy in January

In times of high inflation, value stocks tend to outperform growth stocks and have done so over the past year. Amid the rising inflationary pressure and looming interest rate hikes, fundamentally sound value stocks ArcelorMittal (MT), Covestro (COVTY), KT Corporation (KT), and Nature’s Sunshine (NATR) could be solid bets.

:  |  News, Ratings, and Charts

Stock Market “Nausea Index” Going Off

The stock market (SPY) has seen fresh lows this week scaring many investors into selling their positions. On the other hand, 40 year investment veteran shares a proprietary market indicator that points to a significant bounce coming soon. Is he right? You be the judge by reading below.

Read More Stories

More SmileDirectClub Inc. (SDC) News View All

Event/Date Symbol News Detail Start Price End Price Change POWR Rating
Loading, please wait...
View All SDC News